Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies

被引：0
|
作者：
Laura C. Coates
Johan K. Wallman
Dennis McGonagle
Georg A. Schett
Iain B. McInnes
Philip J. Mease
Lawrence Rasouliyan
Erhard Quebe-Fehling
Darren L. Asquith
Andreas E. R. Fasth
Luminita Pricop
Corine Gaillez
机构：
[1] University of Oxford,Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre
[2] Lund University,Department of Clinical Sciences Lund, Rheumatology, Skåne University Hospital
[3] University of Leeds,undefined
[4] University of Erlangen-Nuremberg,undefined
[5] University of Glasgow,undefined
[6] Swedish Medical Centre and University of Washington,undefined
[7] RTI Health Solutions,undefined
[8] Novartis Pharma AG,undefined
[9] Novartis Pharmaceuticals UK Ltd.,undefined
[10] Novartis Sverige AB,undefined
[11] Novartis Pharmaceuticals Corporation,undefined
来源：
Arthritis Research & Therapy | / 21卷
关键词：
Psoriatic arthritis; Enthesitis; Secukinumab; Interleukin 17A inhibitor; Anti-TNF; Biologics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis
    Wu, Ping
    Huang, Chunlin
    Liao, Pei-Fen
    Ruperto, Nicolino
    Zeng, Huasong
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (11) : 2119 - 2121
  • [22] Efficacy of Secukinumab in Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis Subtypes of Juvenile Idiopathic Arthritis: Results from a Randomized, Phase 3 Study
    Brunner, Hermine
    Chertok, Elena
    Dehoorne, Joke
    Horneff, Gerd
    Kallinich, Tilmann
    Louw, Ingrid
    Alessio, Maria
    Compeyrot-Lacassagne, Sandrine
    Lauwerys, Bernard
    Martin, Neil
    Marzan, Katherine
    Knibbe, W. Patrick
    Martin, Ruvie
    Zhu, Xuan
    Whelan, Sarah
    Pricop, Luminita
    Lovell, Daniel
    Martini, Alberto
    Ruperto, Nicola
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4382 - 4385
  • [23] Secukinumab Treatment in Children and Adolescents with Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis: Efficacy and Safety Results from a Phase 3 Study
    Brunner, Hermine
    Foeldvari, Ivan
    Alexeeva, Ekaterina
    Ayaz, Nuray
    Calvo Penads, Inmaculada
    Kasapcopur, Ozgur
    Chasnyk, Vyacheslav
    Hufnagel, Markus
    Zuber, Zbigniew
    Schulert, Grant
    Ozen, Seza
    Popov, Artem
    Ramanan, Athimalaipet
    Scott, Christiaan
    Sozeri, Betul
    Zholobova, Elena
    Zhu, Xuan
    Whelan, Sarah
    Pricop, Luminita
    Ravelli, Angelo
    Martini, Alberto
    Lovell, Daniel
    Ruperto, Nicolino
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2987 - 2990
  • [24] SECUKINUMAB TREATMENT IN CHILDREN AND ADOLESCENTS WITH ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: EFFICACY AND SAFETY RESULTS FROM A PHASE 3 STUDY
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Foeldvari, Ivan
    Alexeeva, Ekaterina
    Ayaz, Nuray A.
    Calvo, Inmaculada
    Kasapcopur, Ozgur
    Chasnyk, Vyacheslav G.
    Hufnagel, Markus
    Zuber, Zbigniew
    Schulert, Grant
    Ozen, Seza
    Popov, Artem
    Scott, Christiaan
    Sozeri, Betul
    Zholobova, Elena
    Zhu, Xuan
    Whelan, Sarah
    Pricop, Luminita
    Ravelli, Angelo
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    [J]. RHEUMATOLOGY, 2022, 61
  • [25] Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies
    McGonagle, Dennis
    McInnes, Iain B.
    Deodhar, Atul
    Schett, Georg
    Shawi, May
    Kafka, Shelly
    Karyekar, Chetan S.
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Xu, Xie L.
    Sheng, Shihong
    Agarwal, Prasheen
    Zhou, Bei
    Ritchlin, Christopher T.
    Rahman, Proton
    Mease, Philip J.
    [J]. RHEUMATOLOGY, 2021, 60 (11) : 5337 - 5350
  • [26] SECUKINUMAB PROVIDES CLINICAL IMPROVEMENTS IN PATIENTS WITH ACTIVE OLIGOARTICULAR PSORIATIC ARTHRITIS: RESULTS FROM A POOLED ANALYSIS OF FIVE PHASE 3 STUDIES
    Coates, Laura C.
    Ogdie, Alexis
    Gladman, Dafna D.
    Pournara, Effie
    Meng, Xiangyi
    Parikh, Bhumik
    Mease, Philip J.
    [J]. RHEUMATOLOGY, 2022, 61
  • [27] Secukinumab Provides Clinical Improvements in Patients with Active Oligoarticular Psoriatic Arthritis: Results from a Pooled Analysis of 5 Phase 3 Studies
    Ogdie, Alexis
    Gladman, Dafna
    Coates, Laura
    Pournara, Effie
    Meng, Xiangyi
    Parikh, Bhumik
    Mease, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3812 - 3815
  • [28] Presence of psoriatic arthritis has no impact on the clinical efficacy and safety of secukinumab in patients with psoriasis: Pooled analysis of the phase 3 CLEAR and CLARITY trials
    Bagel, Jerry
    Blauvelt, Andrew
    Tyring, Stephen
    Patekar, Manmath
    Meng, Xiangyi
    Lebwohl, Mark
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB69 - AB69
  • [29] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES
    Schett, Georg
    Baraliakos, Xenofon
    van den Bosch, Filip
    Deodhar, Atul
    Gensler, Lianne S.
    Ostergaard, Mikkel
    Agawane, Shital
    Das Gupta, Ayan
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Shete, Abhijit
    Porter, Brian
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 873 - 874
  • [30] Presence of psoriatic arthritis has no impact on the clinical efficacy and safety of secukinumab in patients with psoriasis: Pooled analysis of four phase 3 clinical trials
    Gottlieb, Alice B.
    Armstrong, April W.
    Elewski, Boni Elizabeth
    Merola, Joseph F.
    Gomez, Braulio
    Meng, Xiangyi
    Marfo, Kwaku
    Lebwohl, Mark
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB148 - AB148
12345